Who owns the TRANSLATIONAL PHARMACEUTICS trademark?

The TRANSLATIONAL PHARMACEUTICS trademark is owned by Quotient Sciences Ltd.

What class is the TRANSLATIONAL PHARMACEUTICS trademark registered in?

The TRANSLATIONAL PHARMACEUTICS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for TRANSLATIONAL PHARMACEUTICS?

The USPTO serial number for TRANSLATIONAL PHARMACEUTICS is 79331241.

What is the registration number for TRANSLATIONAL PHARMACEUTICS?

TRANSLATIONAL PHARMACEUTICS is registered under USPTO registration number 7561313.

TRANSLATIONAL PHARMACEUTICS - Owned by Quotient Sciences Ltd - (Class 042)

What to file next

Section 8 declaration of continued use

When: Due between the fifth and sixth anniversary of registration.
Extensions and grace: A six-month grace period follows, with an added per-class fee.
If it is missed: A missed Section 8 cancels the registration, and there is no revival route for it.

How the Section 8 deadline works

General information about USPTO practice, not legal advice. The register is the authority, and a filing that has not yet posted can change what is owed.

Full Goods & Services

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Filing Basis & Declarations

Standard Characters Claimed

Status History

37 events

FINAL DECISION TRANSACTION PROCESSED BY IB

May 03, 2025

Code FINV

FINAL DISPOSITION PROCESSED

Apr 11, 2025

Code FIMP

FINAL DISPOSITION NOTICE SENT TO IB

Apr 11, 2025

Code FICS

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Feb 12, 2025

Code FICR

REGISTERED-PRINCIPAL REGISTER

Nov 12, 2024

Code R.PR

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Nov 12, 2024

Code NRCC

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Sep 12, 2024

Code REAP

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Sep 12, 2024

Code ARAA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Sep 12, 2024

Code TCCA

PUBLISHED FOR OPPOSITION

Aug 27, 2024

Code PUBO

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 27, 2024

Code NPUB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 07, 2024

Code NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 23, 2024

Code CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 14, 2023

Code TEME

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Oct 13, 2023

Code ERFR

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 13, 2023

Code CRFA

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Jul 10, 2023

Code OPNX

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Jun 21, 2023

Code OPNR

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Jun 20, 2023

Code OPNS

FINAL REFUSAL WRITTEN

Apr 13, 2023

Code CNFR

FINAL REFUSAL E-MAILED

Apr 13, 2023

Code GNFR

NOTIFICATION OF FINAL REFUSAL EMAILED

Apr 13, 2023

Code GNFN

ASSIGNED TO EXAMINER

Mar 01, 2023

Code DOCK

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 28, 2023

Code TEME

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 27, 2023

Code TROA

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 27, 2023

Code CRFA

REFUSAL PROCESSED BY IB

Sep 20, 2022

Code RFNT

REFUSAL PROCESSED BY MPU

Aug 26, 2022

Code RFRR

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Aug 26, 2022

Code RFCS

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Aug 25, 2022

Code RFCR

NON-FINAL ACTION WRITTEN

Aug 24, 2022

Code CNRT

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Aug 23, 2022

Code RFCR

NON-FINAL ACTION WRITTEN

Aug 22, 2022

Code CNRT

ASSIGNED TO EXAMINER

Aug 17, 2022

Code DOCK

APPLICATION FILING RECEIPT MAILED

Jan 25, 2022

Code MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 21, 2022

Code NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Jan 20, 2022

Code REPR

Other Marks by Quotient Sciences Ltd

Additional USPTO filings from the same owner.

SYN

SYNTHESIS-TO-CLINIC

79336901

Quotient Sciences Ltd

REGISTERED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

NVP

NV PHARMACEUTICS

99034672

NV Pharmaceutics LLC

REGISTERED

CAT

CATALENT XPRESS PHARMACEUTICS

97596774

R.P. SCHERER TECHNOLOGIES, LLC

REGISTERED

INT

INTEGRATED TRANSLATIONAL IMAGING

88569818

Translational Imaging Innovations, Inc.

REGISTERED

REV

REVERSE TRANSLATIONAL MEDICINE

85984179

Neurimmune Holding AG

REGISTERED

Other Marks by Christopher Turk

Additional USPTO filings handled by the same attorney of record.

RAD

RADIO ZINDAGI

98512466

REGISTERED

BIB

BIBI ZEN LAURANT

90047138

REGISTERED

10V

10 VENDEMMIE TENUTA ULISSE

79271230

REGISTERED

BEL

BELGIAN LINEN

98256556

REGISTERED

TRANSLATIONAL PHARMACEUTICS

What to file next

Full Goods & Services

Filing Basis & Declarations

Other Marks by Quotient Sciences Ltd

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Christopher Turk

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Industries

USPTO Deadlines

Compare

Resources

Company

Exceptions